ORG Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133K Buy
353,924
+348,961
+7,031% +$20M 0.02% 277
2026
Q1
$301K Buy
4,963
+696
+16% +$40.6K 0.06% 179
2025
Q4
$230K Buy
4,267
+3,615
+554% +$174K 0.05% 183
2025
Q3
$29.4K Hold
652
0.01% 354
2025
Q2
$31K Hold
652
0.01% 362
2025
Q1
$38.8K Hold
652
0.01% 371
2024
Q4
$36.9K Hold
652
0.01% 270
2024
Q3
$33.7K Buy
+652
New +$30.6K 0.01% 276

Other funds holding BMY

ORG Wealth Partners's BMY Position: Q2 2026 in Review

ORG Wealth Partners increased its Bristol-Myers Squibb (BMY) stake by 7,031% in Q2 2026, buying an estimated $20M and bringing the position to 353,924 shares worth $133K. The position accounts for 0.02% of the portfolio, ranked #277.

ORG Wealth Partners first reported a position in BMY in Q3 2024 and has held it in 8 quarters since. The position peaked at $301K in Q1 2026. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • ORG Wealth Partners held 353,924 shares of Bristol-Myers Squibb worth $133K as of Q2 2026.
  • ORG Wealth Partners bought 348,961 Bristol-Myers Squibb shares in Q2 2026, an estimated $20M.
  • Bristol-Myers Squibb made up 0.02% of ORG Wealth Partners's portfolio in Q2 2026, its #277 holding.
  • ORG Wealth Partners first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 8 quarters since.
  • ORG Wealth Partners's Bristol-Myers Squibb position peaked at $301K in Q1 2026.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.